Valuation: Tsumura & Co.

Market Cap 288B 1.76B 1.55B 1.44B 1.32B 2.49B 170B 2.52B 17.1B 6.69B 83.32B 6.62B 6.48B P/E 2027 *
11.1x
P/E 2028 * 10.7x
Enterprise Value 385B 2.36B 2.07B 1.92B 1.76B 3.32B 228B 3.37B 22.87B 8.95B 111B 8.86B 8.67B EV / Sales 2027 *
1.78x
EV / Sales 2028 * 1.86x
Free-Float
88.75%
Yield 2027 *
4.09%
Yield 2028 * 4.47%
1 day-1.01%
1 week-1.01%
Current month+2.77%
1 month+2.85%
3 months+3.63%
6 months-8.70%
Current year-6.25%
1 week 3,792
Extreme 3792
3,929
1 month 3,696
Extreme 3696
3,929
Current year 3,513
Extreme 3513
4,403
1 year 3,418
Extreme 3418
4,403
3 years 2,551
Extreme 2551
5,138
5 years 2,536
Extreme 2536
5,138
10 years 2,189
Extreme 2189
5,138
Manager TitleAgeSince
Chief Executive Officer 62 2019-05-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 76 2018-05-31
Director/Board Member 62 2011-05-31
Director/Board Member 70 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-1.01%+4.71%+44.06% 1.76B
-1.05%+0.55%+49.79%+151.71% 1,037B
+2.00%+3.49%+52.22%+50.20% 615B
-1.09%+3.76%+35.37%+76.22% 448B
+2.77%+2.86%+30.54%+24.72% 326B
-0.80%+1.07%+33.78%+37.20% 293B
-1.29%-0.32%+17.93%+16.77% 264B
-1.69%-6.61%-29.18%-42.98% 216B
-0.05%+2.16%+19.75%+55.89% 198B
+0.05%-1.03%+18.31%+61.63% 162B
Average -0.17%+1.02%+23.32%+47.54% 355.92B
Weighted average by Cap. -0.13%+1.47%+35.05%+72.36%

Financials

2027 *2028 *
Net sales 217B 1.33B 1.16B 1.08B 993M 1.87B 128B 1.9B 12.88B 5.04B 62.75B 4.99B 4.88B 229B 1.4B 1.23B 1.14B 1.05B 1.98B 136B 2.01B 13.61B 5.33B 66.31B 5.27B 5.16B
Net income 26.04B 160M 140M 130M 119M 225M 15.41B 228M 1.55B 606M 7.54B 599M 586M 26.96B 165M 145M 134M 124M 233M 15.95B 236M 1.6B 627M 7.8B 621M 607M
Net Debt 97.06B 595M 521M 484M 445M 838M 57.42B 850M 5.77B 2.26B 28.1B 2.23B 2.19B 138B 849M 744M 690M 634M 1.2B 81.88B 1.21B 8.22B 3.22B 40.07B 3.19B 3.12B
Logo Tsumura & Co.
Tsumura & Co is a Japan-based company mainly engaged in manufacturing and sales of prescription drugs and over-the-counter drugs. The Company operates the Pharmaceuticals segment. In Japan, the Company conducts the manufacturing, sales, transportation and storage of prescription drugs and over-the-counter drugs, and cultivation, procurement, selection, processing and storage of raw medicinal herbs. In China, the Company is engaged in regional management, business management, production and sales of herbal extract powders, cultivation, procurement, selection, processing and storage of herbal ingredients, and sales of pharmaceuticals and food products. In Laos, the Company is engaged in cultivation, procurement, selection, processing and storage of herbal ingredients. In the United States, the Company is engaged in pharmaceutical development business.
Employees
4,923
Date Price Change Volume
26-07-23 JP¥3,822.00 -1.01% 294,200
26-07-22 JP¥3,861.00 -0.49% 262,200
26-07-21 JP¥3,880.00 +0.78% 354,900
26-07-17 JP¥3,850.00 -0.28% 342,800
26-07-16 JP¥3,861.00 +0.16% 296,100
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
3,861.00JPY
Average target price
4,400.00JPY
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4540 Stock